Company: PSTV
Filing Date: 2025-06-20
Form Type: 8-K
Source: 0001193125-25-143665
Chunk: 2

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-06-20
Form: 8-K
Item: Item 1.01
Chunk 2
---
 of its common stock of up to the lesser of:

  30% of the aggregate number of shares of the Company’s common stock traded during a certain portion of the normal trading hours on such Accelerated Purchase Date as determined in accordance wit...  

  300% of the number of purchase shares purchased pursuant to the Regular Purchase corresponding to the Accelerated Purchase that was completed on such Accelerated Purchase Date on which an Addit...  

The Company may, in its sole discretion, submit multiple Additional Accelerated Purchase notices to Lincoln Park prior to 1:00 p. m., Eastern time, on a single Accelerated Purchase Date (the “ Additional Accelerated Purchase Date”), provided that all prior Accelerated Purchases and Additional Accelerated Purchases (including those that have occurred earlier on the same day) have been completed and all of the shares of the Company’s common stock to be purchased thereunder (and under the corresponding Regular Purchase) have been properly delivered to Lincoln Park in accordance with the Purchase Agreement.

The purchase price per share for each such Additional Accelerated Purchase will be equal to 96.5% of the lower of:

  the volume weighted average price of the Company’s common stock during the applicable Additional Accelerated Purchase Measurement Period on the applicable Additional Accelerated Purchase Date; and  

  the closing sale price of the Company’s common stock on the applicable Additional Accelerated Purchase Date.  

In the case of Regular Purchases, Accelerated Purchases and Additional Accelerated Purchases, the purchase price per share will be equitably adjusted for any reorganization, recapitalization, non-cashdividend, stock split, reverse stock split or other similar transaction occurring during the business days used to compute the purchase price.

The Company will need stockholder approval before issuing more than 10,194,593 shares (including any shares issuable to Lincoln Park under the Purchase Agreement in consideration for its commitment to purchase shares of the Company’s common stock, the “ Exchange Cap”), which represents 19.99% of its outstanding shares immediately prior to the execution of the Purchase Agreement, unless (i) the Company obtains stockholder approval to issue shares of its common stock in excess of the Exchange Cap or (ii) the average price of all applicable sales of its common stock to Lincoln Park under the Purchase Agreement equals or exceeds $0.3576 per share (which represents the sum of (i) $0.3086, representing the lower of (A) the official closing price of the Company’s common stock on Nasdaq immediately preceding